Afcc, Llc - Net Worth and Insider Trading

Afcc, Llc Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Afcc, Llc owns 1 companies in total, including Bioxytran Inc (BIXT) .

Click here to see the complete history of Afcc, Llc’s form 4 insider trades.

Insider Ownership Summary of Afcc, Llc

Ticker Comapny Transaction Date Type of Owner
BIXT Bioxytran Inc 2017-12-06 10 percent owner

Afcc, Llc Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Afcc, Llc Ownership Network

Ownership Network List of Afcc, Llc

No Data

Ownership Network Relation of Afcc, Llc

Insider Network Chart

Afcc, Llc Owned Company Details

What does Bioxytran Inc do?

Who are the key executives at Bioxytran Inc?

Afcc, Llc is the 10 percent owner of Bioxytran Inc. Other key executives at Bioxytran Inc include director & 10 percent owner & CEO David Platt , Chief Communication Officer Michael Sheikh , and other: No longer 10% owner Binder Offer .

Bioxytran Inc (BIXT) Insider Trades Summary

Over the past 18 months, Afcc, Llc made no insider transaction in Bioxytran Inc (BIXT). Other recent insider transactions involving Bioxytran Inc (BIXT) include a net purchase of 1,592,921 shares made by David Platt ,

In summary, during the past 3 months, insiders sold 0 shares of Bioxytran Inc (BIXT) in total and bought 1,592,921 shares, with a net purchase of 1,592,921 shares. During the past 18 months, 0 shares of Bioxytran Inc (BIXT) were sold and 1,592,921 shares were bought by its insiders, resulting in a net purchase of 1,592,921 shares.

Bioxytran Inc (BIXT)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Bioxytran Inc Insider Transactions

No Available Data

Afcc, Llc Mailing Address

Above is the net worth, insider trading, and ownership report for Afcc, Llc. You might contact Afcc, Llc via mailing address: 1621 Central Avenue, Cheyenne Wy 82001.

Discussions on Afcc, Llc

No discussions yet.